Clinical Trial Update: Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating leflunomide for chronic musculoskeletal graft-versus-host disease after allogeneic stem cell transplantation has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Musculoskeletal Diseases

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Musculoskeletal Disease Other, GVHD, Chronic | Phase 2 | Status: TERMINATED